XML 16 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

On August 26, 2024, Chad Robins, Chief Executive Officer and Director, adopted a Rule 10b5-1 trading plan. Mr. Robins’s plan provides for the sale of up to 755,555 shares of our common stock until June 9, 2025. This plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and our policies regarding transactions in our securities.

Additionally, on August 26, 2024, Harlan Robins, Chief Scientific Officer, adopted a Rule 10b5-1 trading plan. Dr. Robins’s plan provides for the sale of up to 70,110 shares of our common stock until June 9, 2025. This plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and our policies regarding transactions in our securities.
Chad Robins [Member]  
Trading Arrangements, by Individual  
Name Chad Robins
Title Chief Executive Officer and Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date August 26, 2024
Expiration Date June 9, 2025
Arrangement Duration 9 months 15 days
Aggregate Available 755,555
Harlan Robins [Member]  
Trading Arrangements, by Individual  
Name Harlan Robins
Title Chief Scientific Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date August 26, 2024
Expiration Date June 9, 2025
Arrangement Duration 9 months 15 days
Aggregate Available 70,110